SC
Stephen P. Carey
SVP & CFO

Stephen P. Carey insider trades: Ani Pharmaceuticals (ANIP) stock sales

SVP & CFO, Ani Pharmaceuticals Last trade Oct 29, 2026 48 Form 4 filings
$2.0M
Sold, last 12 months
7 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stephen reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 29, 2026ANIP↓ Sell$208K
Sep 29, 2026ANIP↓ Sell$208K
Aug 31, 2026ANIP↓ Sell$207K
Jul 29, 2026ANIP↓ Sell$232K
Jul 2, 2026ANIP↓ Sell$285K
Jun 5, 2026ANIP↓ Sell$265K
Mar 5, 2026ANIP↓ Sell$552K
Aug 12, 2025ANIP↓ Sell$4.3M
Dec 17, 2024ANIP↓ Sell$418K
Jun 4, 2024ANIP↓ Sell$318K
Mar 11, 2024ANIP↓ Sell$510K
Aug 14, 2023ANIP↓ Sell$1.1M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANIP insiders

Open-market trades in the last 12 months

About Stephen P. Carey's insider trades

Stephen P. Carey is SVP & CFO at Ani Pharmaceuticals (ANIP). Since Aug 14, 2023, Stephen has reported no open-market purchases and 12 sales worth $8.6M on SEC Form 4. In the last 12 months: 7 sales ($2.0M).

Their filings also include shares withheld for taxes (27 filings), grants and awards (12 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.